Evidence map›Paper›PMID 37895844›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Quality, Safety and Biological Studies on

Katelene Lima, Maryam Malmir, Sérgio P Camões, Kamrul Hasan, Samuel Gomes, Isabel Moreira da Silva, Maria Eduardo Figueira, Joana P Miranda, Rita Serrano, Maria Paula Duarte and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Effects ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Katelene LimaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0002-1424-7229
Maryam MalmirResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0002-1738-3429
Sérgio P CamõesResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0003-0355-5338
Kamrul HasanResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0002-6933-8486
Samuel GomesInstituto Nacional de Investigação e Desenvolvimento Agrário (INIDA), São Jorge dos Orgãos, Santiago CP 84, Cabo Verde.
Isabel Moreira da SilvaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0003-4415-7950
Maria Eduardo FigueiraResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0002-1561-6858
Joana P MirandaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0002-7804-4068
Rita SerranoResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0001-6549-8047
Maria Paula DuarteThe Mechanical Engineering and Resource Sustainability Center (MEtRICs), Nova School of Science and Technology, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.
Olga SilvaResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.ORCID 0000-0003-1555-7883
University of Lisbon · PTInstituto Nacional de Desenvolvimento das Pescas · CVUniversidade Nova de Lisboa · PT

Funding

Fundação para a Ciência e Tecnologia UIDB/04077/2020Fundação para a Ciência e Tecnologia UIDP/04077/2020Fundação para a Ciência e Tecnologia UIDP/04138/2020
6 · The paper itself

Abstract

In Cabo Verde, several endemic species are used in traditional medicine. However, no scientific studies have been conducted on the quality, efficacy, and safety of most of these plants. This study focused on establishing the botanical and chemical identification parameters required for a quality monograph of

Indexed as

antihyperglycemicantioxidantCampylanthus glaberherbal drugherbal medicinequality controlsafetyverbascoside

Identifiers

PMID37895844
PMCPMC10610246
OpenAlexW4387120637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.